Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Onkologie 2007;30:185-191, ISSN: 0378-584X
- Event
-
Veröffentlichung
- (where)
-
Dresden
- (who)
-
Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
- (when)
-
2014
- Creator
-
Schuler, Ulrich
Bammer, Susanne
Aulitzky, Walter E.
Binder, Claudia
Böhme, Angelika
Egerer, Gerlinde
Sandherr, Michael
Schwerdtfeger, Rainer
Silling, Gerda
Wandt, Hannes
Glasmacher, Axel
Ehninger, Gerhard
- URN
-
urn:nbn:de:bsz:14-qucosa-134972
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schuler, Ulrich
- Bammer, Susanne
- Aulitzky, Walter E.
- Binder, Claudia
- Böhme, Angelika
- Egerer, Gerlinde
- Sandherr, Michael
- Schwerdtfeger, Rainer
- Silling, Gerda
- Wandt, Hannes
- Glasmacher, Axel
- Ehninger, Gerhard
- Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden
Time of origin
- 2014
Other Objects (12)
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Application of Genomics to Clinical Practice in Haematological Malignancy
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
Antifungal activity of essential oils and their potential synergistic effect with amphotericin B
Antifungal Activity of Statins and their Interaction with Amphotericin B Against Clinically Important Zygomycetes
Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B
Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function
Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer
Granulocyte-Monocyte Colony Forming Unit Content of Autologous Bone Marrow Transplants in Patients with Haematological Malignancy
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Application of Genomics to Clinical Practice in Haematological Malignancy
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
Antifungal activity of essential oils and their potential synergistic effect with amphotericin B
Antifungal Activity of Statins and their Interaction with Amphotericin B Against Clinically Important Zygomycetes
Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B
Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function
Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer
Granulocyte-Monocyte Colony Forming Unit Content of Autologous Bone Marrow Transplants in Patients with Haematological Malignancy
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
Fluconazole for empiric antifungal therapy in cancer patients with fever and neutropenia
Optimization of Antifungal Prophylaxis in Haematological High-Risk Patients
Application of Genomics to Clinical Practice in Haematological Malignancy
Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome
Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report
Antifungal activity of essential oils and their potential synergistic effect with amphotericin B
Antifungal Activity of Statins and their Interaction with Amphotericin B Against Clinically Important Zygomycetes
Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B
Immunophenotyping patients with sepsis and underlying haematological malignancy reveals defects in monocyte and lymphocyte function
Enhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block Copolymer
Granulocyte-Monocyte Colony Forming Unit Content of Autologous Bone Marrow Transplants in Patients with Haematological Malignancy
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections